116 related articles for article (PubMed ID: 30471171)
1. Carborane-Based Analogues of 5-Lipoxygenase Inhibitors Co-inhibit Heat Shock Protein 90 in HCT116 Cells.
Kuhnert R; Sárosi MB; George S; Lönnecke P; Hofmann B; Steinhilber D; Steinmann S; Schneider-Stock R; Murganić B; Mijatović S; Maksimović-Ivanić D; Hey-Hawkins E
ChemMedChem; 2019 Jan; 14(2):255-261. PubMed ID: 30471171
[TBL] [Abstract][Full Text] [Related]
2. CarbORev-5901: The First Carborane-Based Inhibitor of the 5-Lipoxygenase Pathway.
Kuhnert R; Sárosi MB; George S; Lönnecke P; Hofmann B; Steinhilber D; Murganic B; Mijatovic S; Maksimovic-Ivanic D; Hey-Hawkins E
ChemMedChem; 2017 Jul; 12(13):1081-1086. PubMed ID: 28569429
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and In Vitro Biological Evaluation of
Braun S; Jelača S; Laube M; George S; Hofmann B; Lönnecke P; Steinhilber D; Pietzsch J; Mijatović S; Maksimović-Ivanić D; Hey-Hawkins E
Molecules; 2023 Jun; 28(11):. PubMed ID: 37299023
[TBL] [Abstract][Full Text] [Related]
4. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells.
Massey AJ; Williamson DS; Browne H; Murray JB; Dokurno P; Shaw T; Macias AT; Daniels Z; Geoffroy S; Dopson M; Lavan P; Matassova N; Francis GL; Graham CJ; Parsons R; Wang Y; Padfield A; Comer M; Drysdale MJ; Wood M
Cancer Chemother Pharmacol; 2010 Aug; 66(3):535-45. PubMed ID: 20012863
[TBL] [Abstract][Full Text] [Related]
5. Carborane-Based Tebufelone Analogs and Their Biological Evaluation In Vitro.
Braun S; Paskaš S; Laube M; George S; Hofmann B; Lönnecke P; Steinhilber D; Pietzsch J; Mijatović S; Maksimović-Ivanić D; Hey-Hawkins E
ChemMedChem; 2023 Jul; 18(14):e202300206. PubMed ID: 37160667
[TBL] [Abstract][Full Text] [Related]
6. Hsp90 inhibitors sensitise human colon cancer cells to topoisomerase I poisons by depletion of key anti-apoptotic and cell cycle checkpoint proteins.
McNamara AV; Barclay M; Watson AJ; Jenkins JR
Biochem Pharmacol; 2012 Feb; 83(3):355-67. PubMed ID: 22138446
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein-4 inhibits heat-induced apoptosis by modulating MAPK pathways in human colon cancer HCT116 cells.
Deng H; Ravikumar TS; Yang WL
Cancer Lett; 2007 Oct; 256(2):207-17. PubMed ID: 17640799
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and computational studies on dihydropyrimidine scaffolds as potential lipoxygenase inhibitors and cancer chemopreventive agents.
Venugopala KN; Govender R; Khedr MA; Venugopala R; Aldhubiab BE; Harsha S; Odhav B
Drug Des Devel Ther; 2015; 9():911-21. PubMed ID: 25733811
[TBL] [Abstract][Full Text] [Related]
9. Borcalein: a Carborane-Based Analogue of Baicalein with 12-Lipoxygenase-Independent Toxicity.
Kuhnert R; Kuhnert L; Sárosi MB; George S; Draca D; Paskas S; Hofmann B; Steinhilber D; Honscha W; Mijatović S; Maksimović-Ivanić D; Hey-Hawkins E
ChemMedChem; 2022 Jan; 17(1):e202100588. PubMed ID: 34694057
[TBL] [Abstract][Full Text] [Related]
10. In silico carborane docking to proteins and potential drug targets.
Calvaresi M; Zerbetto F
J Chem Inf Model; 2011 Aug; 51(8):1882-96. PubMed ID: 21774557
[TBL] [Abstract][Full Text] [Related]
11. Reactivation of ERK and Akt confers resistance of mutant BRAF colon cancer cells to the HSP90 inhibitor AUY922.
Wang CY; Guo ST; Wang JY; Yan XG; Farrelly M; Zhang YY; Liu F; Yari H; La T; Lei FX; Jin L; Zhang XD; Jiang CC
Oncotarget; 2016 Aug; 7(31):49597-49610. PubMed ID: 27391062
[TBL] [Abstract][Full Text] [Related]
12. BAG3-dependent expression of Mcl-1 confers resistance of mutant KRAS colon cancer cells to the HSP90 inhibitor AUY922.
Wang CY; Guo ST; Croft A; Yan XG; Jin L; Zhang XD; Jiang CC
Mol Carcinog; 2018 Feb; 57(2):284-294. PubMed ID: 29068469
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and evaluation of semi-synthetic triazole-containing caffeic acid analogues as 5-lipoxygenase inhibitors.
De Lucia D; Lucio OM; Musio B; Bender A; Listing M; Dennhardt S; Koeberle A; Garscha U; Rizzo R; Manfredini S; Werz O; Ley SV
Eur J Med Chem; 2015 Aug; 101():573-83. PubMed ID: 26197161
[TBL] [Abstract][Full Text] [Related]
14. Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer.
Ahn JY; Lee JS; Min HY; Lee HY
Oncotarget; 2015 Oct; 6(32):32622-33. PubMed ID: 26416450
[TBL] [Abstract][Full Text] [Related]
15. Designing therapeutically effective 5-lipoxygenase inhibitors.
McMillan RM; Walker ER
Trends Pharmacol Sci; 1992 Aug; 13(8):323-30. PubMed ID: 1413091
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of 5-lipoxygenase in colon polyps and cancer and the effect of 5-LOX inhibitors in vitro and in a murine model.
Melstrom LG; Bentrem DJ; Salabat MR; Kennedy TJ; Ding XZ; Strouch M; Rao SM; Witt RC; Ternent CA; Talamonti MS; Bell RH; Adrian TA
Clin Cancer Res; 2008 Oct; 14(20):6525-30. PubMed ID: 18927292
[TBL] [Abstract][Full Text] [Related]
17. Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors.
Zaarur N; Gabai VL; Porco JA; Calderwood S; Sherman MY
Cancer Res; 2006 Feb; 66(3):1783-91. PubMed ID: 16452239
[TBL] [Abstract][Full Text] [Related]
18. Structure based design of heat shock protein 90 inhibitors acting as anticancer agents.
Doddareddy MR; Thorat DA; Seo SH; Hong TJ; Cho YS; Hahn JS; Pae AN
Bioorg Med Chem; 2011 Mar; 19(5):1714-20. PubMed ID: 21306907
[TBL] [Abstract][Full Text] [Related]
19. NMR metabolomics analysis of the effects of 5-lipoxygenase inhibitors on metabolism in glioblastomas.
Morin P; Ferguson D; LeBlanc LM; Hébert MJ; Paré AF; Jean-François J; Surette ME; Touaibia M; Cuperlovic-Culf M
J Proteome Res; 2013 May; 12(5):2165-76. PubMed ID: 23557402
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in the search for novel 5-lipoxygenase inhibitors for the treatment of asthma.
Bruno F; Spaziano G; Liparulo A; Roviezzo F; Nabavi SM; Sureda A; Filosa R; D'Agostino B
Eur J Med Chem; 2018 Jun; 153():65-72. PubMed ID: 29133059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
